Skip to main content

Table 4 B vitamin biomarkers before and after intervention with a B vitamin-fortified and placebo drink

From: Effectiveness of a fortified drink in improving B vitamin biomarkers in older adults: a controlled intervention trial

 

Placebo

Active

P value

Pre-intervention

Post-intervention

Pre-intervention

Post-intervention

Plasma Total 25(OH)D (nmol/L)

62.5 (22.4)

66.9 (17.0)

59.3 (25.20)

65.5 (25.8)

0.727

Serum homocysteine (µmol/L)

11.1 (9.7–12.8)

11.3 (9.9–13.2)

11.9 (10.3–15.1)

10.6 (9.4–13.0)

0.000240

Serum folate (nmol/L)

18.0 (14.3–22.0)

16.6 (13.0–21.8)

15.5 (11.8–21.6)

17.9 (12.7–23.6)

0.000439

Serum vitamin B12 (pmol/L)

336 (235–449)

342 (268–468)

310 (246–409)

428 (307–549)

0.005

Plasma PLP (vitamin B6; (nmol/L)

61.7 (48.6–85.1)

65.4 (38.3–104.9)

59.4 (44.5–74.1)

253.0 (181.0–351.4)

0.002

Riboflavin (EGRac)

1.29 (1.24–1.35)

1.30 (1.23–1.36)

1.34 (1.25–1.43)

1.14 (1.09–1.23)

3.2014 × 10–9

  1. Data presented as mean (SD) or median (IQR). P value of group effects when analysed by ANCOVA adjusted for baseline values in intention-to-treat analysis. P < 0.05 considered statistically significant. EGRac, erythrocyte glutathione reductase activation coefficient; PLP, Pyridoxal 5′-phosphate